| Taylor Roth, MD | |
|
Keesler Afb, 301 Fisher Street, Biloxi, MS 39534 | |
| (228) 376-2273 | |
| Not Available |
| Full Name | Taylor Roth |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 7 Years |
| Location | Keesler Afb, Biloxi, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437684057 | NPI | - | NPPES |
| 1437684057 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 27856 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ochsner Medical Center-hancock | Bay saint louis, MS | Hospital |
| Memorial Hospital At Gulfport | Gulfport, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hancock Emergency Group Llc | 8022237015 | 15 |
News Archive
A recent study completed at the University of Eastern Finland shows that dietary polyunsaturated fatty acids may reduce the risk of coronary heart disease. The sources of polyunsaturated fatty acids include fish, vegetable oils, and nuts.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that the company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Fertility experts say the women who are heavy smokers are less likely to become pregnant through IVF treatment, even when donated eggs are used.
A Floridian woman, the fourth victim of botulism poisoning contracted from drinking spoiled carrot juice, is suffering from paralysis.
Saint Louis University is participating in a Phase III clinical trial for a drug to treat early-onset preeclampsia in pregnant women that could increase the length of pregnancy, resulting in improved fetal outcomes and reduced infant mortality.
› Verified 7 days ago
| Entity Name | Memorial Hospital At Gulfport |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215546635 PECOS PAC ID: 2466524012 Enrollment ID: O20090515000396 |
News Archive
A recent study completed at the University of Eastern Finland shows that dietary polyunsaturated fatty acids may reduce the risk of coronary heart disease. The sources of polyunsaturated fatty acids include fish, vegetable oils, and nuts.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that the company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Fertility experts say the women who are heavy smokers are less likely to become pregnant through IVF treatment, even when donated eggs are used.
A Floridian woman, the fourth victim of botulism poisoning contracted from drinking spoiled carrot juice, is suffering from paralysis.
Saint Louis University is participating in a Phase III clinical trial for a drug to treat early-onset preeclampsia in pregnant women that could increase the length of pregnancy, resulting in improved fetal outcomes and reduced infant mortality.
› Verified 7 days ago
| Entity Name | Hancock Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295142396 PECOS PAC ID: 8022237015 Enrollment ID: O20140924002285 |
News Archive
A recent study completed at the University of Eastern Finland shows that dietary polyunsaturated fatty acids may reduce the risk of coronary heart disease. The sources of polyunsaturated fatty acids include fish, vegetable oils, and nuts.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that the company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Fertility experts say the women who are heavy smokers are less likely to become pregnant through IVF treatment, even when donated eggs are used.
A Floridian woman, the fourth victim of botulism poisoning contracted from drinking spoiled carrot juice, is suffering from paralysis.
Saint Louis University is participating in a Phase III clinical trial for a drug to treat early-onset preeclampsia in pregnant women that could increase the length of pregnancy, resulting in improved fetal outcomes and reduced infant mortality.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Taylor Roth, MD Keesler Afb, 301 Fisher Street, Biloxi, MS 39534 Ph: (228) 376-2273 | Taylor Roth, MD Keesler Afb, 301 Fisher Street, Biloxi, MS 39534 Ph: (228) 376-2273 |
News Archive
A recent study completed at the University of Eastern Finland shows that dietary polyunsaturated fatty acids may reduce the risk of coronary heart disease. The sources of polyunsaturated fatty acids include fish, vegetable oils, and nuts.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that the company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.
Fertility experts say the women who are heavy smokers are less likely to become pregnant through IVF treatment, even when donated eggs are used.
A Floridian woman, the fourth victim of botulism poisoning contracted from drinking spoiled carrot juice, is suffering from paralysis.
Saint Louis University is participating in a Phase III clinical trial for a drug to treat early-onset preeclampsia in pregnant women that could increase the length of pregnancy, resulting in improved fetal outcomes and reduced infant mortality.
› Verified 7 days ago
Laurie Scott Patterson, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 150 Reynoir Street, Biloxi, MS 39530 Phone: 228-872-9747 | |
Dr. Ryan Anderson, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 301 Fisher St, Biloxi, MS 39534 Phone: 228-376-0500 | |
Raychel Simpson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 Fisher St, Biloxi, MS 39534 Phone: 228-376-2273 | |
Dr. Christopher Lloyd Smelley, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 Veterans Ave, Biloxi, MS 39531 Phone: 228-523-5000 | |
Dr. Adam L Whitaker, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 150 Reynoir St, Biloxi, MS 39530 Phone: 228-432-1571 | |
Esmael Mayar, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 Fisher St, Biloxi, MS 39534 Phone: 228-376-4021 | |
Dr. Lennis Joseph Derouen, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 979 Tommy Munro Dr, Biloxi, MS 39532 Phone: 228-388-0091 Fax: 228-388-0094 |